{"nctId":"NCT00102518","briefTitle":"Aripiprazole Open-Label, Safety and Tolerability Study","startDateStruct":{"date":"2004-09"},"conditions":["Schizophrenia","Bipolar Disorder"],"count":325,"armGroups":[{"label":"NCT00102063 and NCT00110461 Subjects","type":"EXPERIMENTAL","interventionNames":["Drug: Aripiprazole"]}],"interventions":[{"name":"Aripiprazole","otherNames":["OPC-14597"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Adolescent patients with schizophrenia, or child and adolescent patients with bipolar I disorder, manic or mixed episode\n\nExclusion Criteria:\n\n* Patients with a co-morbid serious, uncontrolled systemic illness\n* Patients with a significant risk of committing suicide","healthyVolunteers":false,"sex":"ALL","minimumAge":"10 Years","maximumAge":"17 Years","stdAges":["CHILD"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Percentage of Subjects Experiencing SAEs","description":"Percentage of Subjects Experiencing SAEs. The incidences of SAEs are summarized by system organ class in CT-8.5.1; by system organ class and MedDRA preferred term and by system organ class, MedDRA preferred term, and severity.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"6.2","spread":null}]}]}]},{"type":"SECONDARY","title":"Change in Change in Positive and Negative Syndrome Scale (PANSS) Total Score","description":"Change from baseline to the last scheduled post-baseline evaluation in PANSS total score, using observed cases (assessments performed at baseline and weeks 4, 12, and 26).\n\nThis scale consists of symptom constructs (7 positive, 7 negative, 16 general psychopathology), each to be rated on a 7-point scale of severity with 1 being absent to 7 being extreme. Minimum score is 30 which is best outcome; maximum score is 210 for worse outcome.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-7.5","spread":"17.89"}]}]}]},{"type":"SECONDARY","title":"Change in Young Mania Rating Scale (Y-MRS) Total Score","description":"Change from baseline to last scheduled post-baseline evaluation in YMRS total score, using observed cases (assessments performed at baseline and weeks 4, 12, and 26).\n\nThe Y-MRS consists of 11 items assessing the core symptoms of mania. Each item has 5 grades of severity. Minimum score on the scale is 0 (absent or normal). Maximum score on the scale is 60 (worse outcome or more severe symptoms).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-7.74","spread":"11.73"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":20,"n":325},"commonTop":["Extrapyramidal disorder","Somnolence","Headache","Akathisia","Insomnia"]}}}